Innovations in Serum and Urine Markers in Prostate Cancer
- 4 July 2005
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 48 (6), 1031-1041
- https://doi.org/10.1016/j.eururo.2005.06.009
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate CancerClinical Chemistry, 2004
- Algorithms based on prostate‐specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false‐postitive PSA results in prostate cancer screeningInternational Journal of Cancer, 2004
- Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancerThe Prostate, 2004
- Total and Gleason Grade 4/5 Cancer Volumes are Major Contributors of Human Kallikrein 2, Whereas Free Prostate Specific Antigen is Largely Contributed by Benign Gland Volume in Serum From Patients With Prostate Cancer or Benign Prostatic BiopsiesJournal of Urology, 2003
- The story of the European Randomized Study of Screening for Prostate CancerBJU International, 2003
- Polymorphisms in the CYP1A1 gene are associated with prostate cancer riskInternational Journal of Cancer, 2003
- Dual-Label Immunoassay for Simultaneous Measurement of Prostate-specific Antigen (PSA)-α1-Antichymotrypsin Complex Together with Free or Total PSAClinical Chemistry, 2003
- Discrimination of Benign From Malignant Prostatic Disease by Selective Measurements of Single Chain, Intact Free Prostate Specific AntigenJournal of Urology, 2002
- PREDICTION OF POST-RADICAL PROSTATECTOMY PATHOLOGICAL OUTCOME FOR STAGE T1c PROSTATE CANCER WITH PERCENT FREE PROSTATE SPECIFIC ANTIGEN: A PROSPECTIVE MULTICENTER CLINICAL TRIALJournal of Urology, 1999
- Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltonsAnalytical Chemistry, 1988